Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study

Sadeleştirilmiş öğe sayfası
dc.contributor.authorAkgun, Zuleyha
dc.contributor.authorSaglam, Sezer
dc.contributor.authorYucel, Serap
dc.contributor.authorGural, Zeynep
dc.contributor.authorBalik, Emre
dc.contributor.authorCipe, Gokhan
dc.contributor.authorYildiz, Seyma
dc.contributor.authorKilickap, Sadettin
dc.contributor.authorOkyar, Alper
dc.contributor.authorKaytan\\-Saglam, Esra
dc.date.accessioned2025-10-16T15:32:29Z
dc.date.issued2014
dc.identifier.doi10.1007/s00280-014-2558-x
dc.identifier.otherWOS:000342419600011
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/9143
dc.publisherSPRINGER
dc.sourceCANCER CHEMOTHERAPY AND PHARMACOLOGY
dc.subjectChronomodulated chemotherapy
dc.subjectCapecitabine
dc.subjectNeoadjuvant chemoradiotherapy
dc.subjectRectal cancer
dc.titleNeoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS